{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["SARS-CoV-2", "bioactive compounds", "molecular docking", "pharmacokinetic", "traditional plants"]], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": ["IM"], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "35566014", "DateCompleted": {"Year": "2022", "Month": "05", "Day": "17"}, "DateRevised": {"Year": "2022", "Month": "12", "Day": "07"}, "Article": {"ArticleDate": [{"Year": "2022", "Month": "04", "Day": "20"}], "Language": ["eng"], "ELocationID": ["2662", "10.3390/molecules27092662"], "Journal": {"ISSN": "1420-3049", "JournalIssue": {"Volume": "27", "Issue": "9", "PubDate": {"Year": "2022", "Month": "Apr", "Day": "20"}}, "Title": "Molecules (Basel, Switzerland)", "ISOAbbreviation": "Molecules"}, "ArticleTitle": "Docking Analysis of Some Bioactive Compounds from Traditional Plants against SARS-CoV-2 Target Proteins.", "Abstract": {"AbstractText": ["COVID-19 is still a global pandemic that has not been stopped. Many traditional medicines have been demonstrated to be incredibly helpful for treating COVID-19 patients while fighting the disease worldwide. We introduced 10 bioactive compounds derived from traditional medicinal plants and assessed their potential for inhibiting viral spike protein (S-protein), Papain-like protease (PLpro), and RNA dependent RNA polymerase (RdRp) using molecular docking protocols where we simulate the inhibitors bound to target proteins in various poses and at different known binding sites using Autodock version 4.0 and Chimera 1.8.1 software. Results found that the chicoric acid, quinine, and withaferin A ligand strongly inhibited CoV-2 S -protein with a binding energy of -8.63, -7.85, and -7.85 kcal/mol, respectively. Our modeling work also suggested that curcumin, quinine, and demothoxycurcumin exhibited high binding affinity toward RdRp with a binding energy of -7.80, -7.80, and -7.64 kcal/mol, respectively. The other ligands, namely chicoric acid, demothoxycurcumin, and curcumin express high binding energy than the other tested ligands docked to PLpro with -7.62, -6.81, and -6.70 kcal/mol, respectively. Prediction of drug-likeness properties revealed that all tested ligands have no violations to Lipinski's Rule of Five except cepharanthine, chicoric acid, and theaflavin. Regarding the pharmacokinetic behavior, all ligand predicted to have high GI-absorption except chicoric acid and theaflavin. At the same way chicoric acid, withaferin A, and withanolide D predicted to be substrate for multidrug resistance protein (P-gp substrate). Caffeic acid, cepharanthine, chicoric acid, withaferin A, and withanolide D also have no inhibitory effect on any cytochrome P450 enzymes. Promisingly, chicoric acid, quinine, curcumin, and demothoxycurcumin exhibited high binding affinity on SARS-CoV-2 target proteins and expressed good drug-likeness and pharmacokinetic properties. Further research is required to investigate the potential uses of these compounds in the treatment of SARS-CoV-2."]}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Food Technology, Arid Lands Cultivation Research Institute (ALCRI), City of Scientific Research and Technological Applications (SRTA-City), Alexandria 21934, Egypt."}], "LastName": "Abd El-Aziz", "ForeName": "Nourhan M", "Initials": "NM"}, {"Identifier": ["0000-0002-7648-2961"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Food Technology Department, Faculty of Agriculture, Benha University, Moshtohor, Benha 13736, Egypt."}], "LastName": "Khalifa", "ForeName": "Ibrahim", "Initials": "I"}, {"Identifier": ["0000-0003-3586-1575"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Food Technology, Arid Lands Cultivation Research Institute (ALCRI), City of Scientific Research and Technological Applications (SRTA-City), Alexandria 21934, Egypt."}], "LastName": "Darwish", "ForeName": "Amira M G", "Initials": "AMG"}, {"Identifier": ["0000-0002-5588-6545"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Food Toxicology and Contaminants, National Research Centre, Dokki, Cairo 12622, Egypt."}], "LastName": "Badr", "ForeName": "Ahmed N", "Initials": "AN"}, {"Identifier": ["0000-0002-1644-5528"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Food Science and Nutrition, College of Sciences, Taif University, P.O. Box 11099, Taif 21944, Saudi Arabia."}], "LastName": "Aljumayi", "ForeName": "Huda", "Initials": "H"}, {"Identifier": ["0000-0003-4044-5103"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Plant Protection and Biomolecular Diagnosis, Arid Lands Cultivation Research Institute (ALCRI), City of Scientific Research and Technological Applications (SRTA-City), Alexandria 21934, Egypt."}], "LastName": "Hafez", "ForeName": "El-Sayed", "Initials": "ES"}, {"Identifier": ["0000-0003-0760-5945"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Food Technology, Arid Lands Cultivation Research Institute (ALCRI), City of Scientific Research and Technological Applications (SRTA-City), Alexandria 21934, Egypt."}, {"Identifier": [], "Affiliation": "Food Research Section, R&D Division, Abu Dhabi Agriculture and Food Safety Authority (ADAFSA), Abu Dhabi P.O. Box 52150, United Arab Emirates."}], "LastName": "Shehata", "ForeName": "Mohamed G", "Initials": "MG"}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "Switzerland", "MedlineTA": "Molecules", "NlmUniqueID": "100964009", "ISSNLinking": "1420-3049"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Antiviral Agents"}, {"RegistryNumber": "0", "NameOfSubstance": "Ligands"}, {"RegistryNumber": "A7V27PHC7A", "NameOfSubstance": "Quinine"}, {"RegistryNumber": "EC 2.7.7.48", "NameOfSubstance": "RNA-Dependent RNA Polymerase"}, {"RegistryNumber": "EC 3.4.-", "NameOfSubstance": "Peptide Hydrolases"}, {"RegistryNumber": "IT942ZTH98", "NameOfSubstance": "Curcumin"}], "MeshHeadingList": [{"QualifierName": ["pharmacology", "therapeutic use"], "DescriptorName": "Antiviral Agents"}, {"QualifierName": [], "DescriptorName": "Curcumin"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": [], "DescriptorName": "Ligands"}, {"QualifierName": [], "DescriptorName": "Molecular Docking Simulation"}, {"QualifierName": [], "DescriptorName": "Peptide Hydrolases"}, {"QualifierName": [], "DescriptorName": "Quinine"}, {"QualifierName": [], "DescriptorName": "RNA-Dependent RNA Polymerase"}, {"QualifierName": [], "DescriptorName": "SARS-CoV-2"}, {"QualifierName": [], "DescriptorName": "COVID-19 Drug Treatment"}], "CoiStatement": "The authors declare no conflict of interest."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Elfiky A.A. Zika Virus: Novel Guanosine Derivatives revealed strong binding and possible inhibition of the polymerase. Future Virol. 2017;12:721\u2013728. doi: 10.2217/fvl-2017-0081.", "ArticleIdList": ["10.2217/fvl-2017-0081"]}, {"Citation": "Hasan A., Paray B.A., Hussain A., Qadir F.A., Attar F., Aziz F.M., Sharifi M., Derakhshankhah H., Rasti B., Mehrabi M., et al. A review on the cleavage priming of the spike protein on coronavirus by angiotensin-converting enzyme-2 and furin. J. Biomol. Struct. Dyn. 2020;39:1\u20139. doi: 10.1080/07391102.2020.1754293.", "ArticleIdList": ["10.1080/07391102.2020.1754293", "PMC7189411", "32274964"]}, {"Citation": "Li F. Structure, function, and evolution of coronavirus spike proteins. Annu. Rev. Virol. 2016;3:237\u2013261. doi: 10.1146/annurev-virology-110615-042301.", "ArticleIdList": ["10.1146/annurev-virology-110615-042301", "PMC5457962", "27578435"]}, {"Citation": "Yan R., Zhang Y., Li Y., Xia L., Guo Y., Zhou Q. Structural basis for the recognition of SARS-CoV-2 by full-length human ACE2. Science. 2020;367:1444\u20131448. doi: 10.1126/science.abb2762.", "ArticleIdList": ["10.1126/science.abb2762", "PMC7164635", "32132184"]}, {"Citation": "Hoffmann M., Kleine-Weber H., Schroeder S., Kruger N., Herrler T., Erichsen S. SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor. Cell. 2020;181:271\u2013280. doi: 10.1016/j.cell.2020.02.052.", "ArticleIdList": ["10.1016/j.cell.2020.02.052", "PMC7102627", "32142651"]}, {"Citation": "Jando J., Camargo S.M.R., Herzog B., Verrey F. Expression and regulation of the neutral amino acid transporter B0AT1 in rat small intestine. PLoS ONE. 2017;12:e0184845. doi: 10.1371/journal.pone.0184845.", "ArticleIdList": ["10.1371/journal.pone.0184845", "PMC5600382", "28915252"]}, {"Citation": "Baig M.S., Alagumuthu M., Rajpoot S., Saqib U. Identification of a Potential Peptide Inhibitor of SARS-CoV-2 Targeting its Entry into the Host Cells. Drugs R&D. 2020;20:161\u2013169. doi: 10.1007/s40268-020-00312-5.", "ArticleIdList": ["10.1007/s40268-020-00312-5", "PMC7319219", "32592145"]}, {"Citation": "Harcourt B.H., Jukneliene D., Kanjanahaluethai A., Bechill J., Severson K.M., Smith C.M. Identification of severe acute respiratory syndrome coronavirus replicase products and characterization of papain-like protease activity. J. Virol. 2004;8:13600\u201313612. doi: 10.1128/JVI.78.24.13600-13612.2004.", "ArticleIdList": ["10.1128/JVI.78.24.13600-13612.2004", "PMC533933", "15564471"]}, {"Citation": "Wertz I.E., Murray J.M. Structurally-defined deubiquitinase inhibitors provide opportunities to investigate disease mechanisms. Drug Discov. Today Technol. 2019;31:109\u2013123.", "ArticleIdList": ["31200854"]}, {"Citation": "Baez-Santos Y.M., St John S.E., Mesecar A.D. The SARS coronavirus papain-like protease: Structure, function and inhibition by designed antiviral compounds. Antivir. Res. 2015;115:21\u201338. doi: 10.1016/j.antiviral.2014.12.015.", "ArticleIdList": ["10.1016/j.antiviral.2014.12.015", "PMC5896749", "25554382"]}, {"Citation": "Sulea T., Lindner H.A., Purisima E.O., M\u00e9nard R. Deubiquitination, a new function of the severe acute respiratory syndrome coronavirus papainlike protease. J. Virol. 2005;79:4550\u20134551. doi: 10.1128/JVI.79.7.4550-4551.2005.", "ArticleIdList": ["10.1128/JVI.79.7.4550-4551.2005", "PMC1061586", "15767458"]}, {"Citation": "Bekes M., van Noort G.J.V., Ekkebus R., Ovaa H., Huang T.T., Lima C.D. Recognition of Lys48-linked di-ubiquitin and deubiquitinating activities of the SARS coronavirus papain-like protease. Mol. Cell. 2016;62:572\u2013585. doi: 10.1016/j.molcel.2016.04.016.", "ArticleIdList": ["10.1016/j.molcel.2016.04.016", "PMC4875570", "27203180"]}, {"Citation": "Elfiky A.A., Ismail A. Molecular dynamics and docking reveal the potency of novel GTP derivatives against RNA dependent RNA polymerase of genotype 4a HCV. Life Sci. 2019;238:116958. doi: 10.1016/j.lfs.2019.116958.", "ArticleIdList": ["10.1016/j.lfs.2019.116958", "31628915"]}, {"Citation": "Abd El-Aziz N.M., Awad O.M., Shehata M.S., El-Sohaimy S.A. Inhibition of the SARS-CoV-2 RNA-Dependent RNA Polymerase by Natural Bioactive Compounds: Molecular Docking Analysis. Egypt. J. Chem. 2021;64:1989\u20132001."}, {"Citation": "Fact Sheet for Healthcare Providers: Emergency Use Authorization for Paxlovid\u2122.  [(accessed on 22 December 2021)]; Available online:  https://www.fda.gov/media/155050/download."}, {"Citation": "Mahase E. COVID-19: UK becomes first country to authorise antiviral molnupiravir. BMJ. 2021;375:n2697. doi: 10.1136/bmj.n2697.", "ArticleIdList": ["10.1136/bmj.n2697", "34737216"]}, {"Citation": "Liu L. Traditional Chinese medicine contributes to the treatment of COVID-19 patients. Chin. Herb. Med. 2020;12:95\u201396. doi: 10.1016/j.chmed.2020.04.003.", "ArticleIdList": ["10.1016/j.chmed.2020.04.003", "PMC7199720", "32391065"]}, {"Citation": "Gautam K., Adhikari R.P., Gupta A.S., Shrestha R.K., Koirala P., Suraj K.S. Self-reported psychological distress during the COVID-19 outbreak in Nepal: Fndings from an online survey. BMC Psychol. 2020;8:127. doi: 10.1186/s40359-020-00497-z.", "ArticleIdList": ["10.1186/s40359-020-00497-z", "PMC7724457", "33298196"]}, {"Citation": "Rastogi A., Bhansali A., Khare N., Suri V., Yaddanapudi N., Sachdeva N., Puri G.D., Malhotra P. Short term, high-dose vitamin D supplementation for COVID-19 disease: A randomised, placebo-controlled, study (SHADE study) Postgrad. Med. J. 2022;98:87\u201390. doi: 10.1136/postgradmedj-2020-139065.", "ArticleIdList": ["10.1136/postgradmedj-2020-139065", "33184146"]}, {"Citation": "Singh P., Guleri R., Singh V., Kaur G., Kataria H., Singh B., Kaur G., Kaul S.C., Wadhwa R., Pati P.K. Biotechnological interventions in Withania somnifera (L.) dunal. Biotechnol. Genet. Eng. Rev. 2015;31:1\u201320. doi: 10.1080/02648725.2015.1020467.", "ArticleIdList": ["10.1080/02648725.2015.1020467", "25787309"]}, {"Citation": "Dhama K., Sharun K., Tiwari R., Dadar M., Malik Y.S., Singh K.P., Chaicumpa W. COVID-19, an emerging coronavirus infection: Advances and prospects in designing and developing vaccines, immunotherapeutics, and therapeutics. Hum. Vaccin Immunother. 2020;16:1232\u20131238. doi: 10.1080/21645515.2020.1735227.", "ArticleIdList": ["10.1080/21645515.2020.1735227", "PMC7103671", "32186952"]}, {"Citation": "Tiwari R., Latheef S.K., Ahmed I., Iqbal H.M.N., Bule M.H., Dhama K., Samad H.A., Karthik K., Alagawany M., El-Hack M.E.A., et al. Herbal Immunomodulators\u2014A remedial panacea for designing and developing effective drugs and medicines: Current scenario and future prospects. Curr. Drug Metab. 2018;19:264\u2013301. doi: 10.2174/1389200219666180129125436.", "ArticleIdList": ["10.2174/1389200219666180129125436", "29380694"]}, {"Citation": "Calland N., Dubuisson J., Rouille Y., Seron K. Hepatitis C virus and natural compounds: A new antiviral approach? Viruses. 2012;4:2197\u20132217. doi: 10.3390/v4102197.", "ArticleIdList": ["10.3390/v4102197", "PMC3497048", "23202460"]}, {"Citation": "Du J., He Z.D., Jiang R.W., Ye W.C., Xu H.X., But P.P.H. Antiviral flavonoids from the root bark of Morus alba L. Phytochemistry. 2003;62:1235\u20131238. doi: 10.1016/S0031-9422(02)00753-7.", "ArticleIdList": ["10.1016/S0031-9422(02)00753-7", "12648543"]}, {"Citation": "Luganini M.E., Terlizzi G., Catucci G., Gilardi M.E., Maffei G.G. The cranberry extract oximacro exerts in vitro virucidal activity against influenza virus by interfering with hemagglutinin. Front. Microbiol. 2018;9:1826.", "ArticleIdList": ["PMC6090095", "30131793"]}, {"Citation": "Xu H.X., Ming D.S., Dong H., But P.P. A new anti-HIV triterpene from Geum japonicum. Chem. Pharm. Bull. 2000;48:1367\u20131369. doi: 10.1248/cpb.48.1367.", "ArticleIdList": ["10.1248/cpb.48.1367", "10993241"]}, {"Citation": "Sahuc M.E., Sahli R., Riviere C., Pene V., Lavie M., Vandeputte A. Dehydrojuncusol, a natural phenanthrene compound extracted from Juncus maritimus, is a new inhibitor of hepatitis C virus RNA replication. J. Virol. 2019;93:e02009\u2013e02018. doi: 10.1128/JVI.02009-18.", "ArticleIdList": ["10.1128/JVI.02009-18", "PMC6498043", "30842319"]}, {"Citation": "Cinatl J., Morgenstern B., Bauer G., Chandra P., Rabenau H., Doerr H.W. Glycyrrhizin, an active component of liquorice roots, and replication of SARS-associated coronavirus. Lancet. 2003;361:2045\u20132046. doi: 10.1016/S0140-6736(03)13615-X.", "ArticleIdList": ["10.1016/S0140-6736(03)13615-X", "PMC7112442", "12814717"]}, {"Citation": "Lin S.C., Ho C.T., Chuo W.H., Li S., Wang T.T., Lin C.C. Effective inhibition of MERS-CoV infection by resveratrol. BMC Infect. Dis. 2017;17:144. doi: 10.1186/s12879-017-2253-8.", "ArticleIdList": ["10.1186/s12879-017-2253-8", "PMC5307780", "28193191"]}, {"Citation": "Elansary H.O., Szopa A., Kubica P., Ekiert H., Ali H.M., Elshikh M.S., Abdel-Salam E.M., El-Esawi M., El-Ansary D.O. Bioactivities of Traditional Medicinal Plants in Alexandria. Evid.-Based Complement. Altern. Med. 2018;1463579:13.", "ArticleIdList": ["PMC5831234", "29636772"]}, {"Citation": "Wang Z., Song Q., Su J., Tang W., Song J., Huang X., An J., Li Y., Ye W., Wang Y. Caffeic acid oligomers from Mesona chinensis and their in vitro antiviral activities. Fitoterapia. 2020;144:104603. doi: 10.1016/j.fitote.2020.104603.", "ArticleIdList": ["10.1016/j.fitote.2020.104603", "32360288"]}, {"Citation": "Liu T., Liu X., Li W. Tetrandrine, a Chinese plant-derived alkaloid, is a potential candidate for cancer chemotherapy. Oncotarget. 2016;7:40800\u201340815. doi: 10.18632/oncotarget.8315.", "ArticleIdList": ["10.18632/oncotarget.8315", "PMC5130046", "27027348"]}, {"Citation": "Bailly C. Cepharanthine: An update of its mode of action, pharmacological properties and medical applications. Phytomedicine. 2019;62:152956. doi: 10.1016/j.phymed.2019.152956.", "ArticleIdList": ["10.1016/j.phymed.2019.152956", "PMC7126782", "31132753"]}, {"Citation": "Zhang C.H., Wang Y.F., Liu X.J., Lu J.H., Qian C.W., Wan Z.Y., Yan X.G., Zheng H.Y., Zhang M.Y., Xiong S., et al. Antiviral activity of cepharanthine against severe acute respiratory syndrome coronavirus in vitro. Chin. Med. J. 2005;20:493\u2013496.", "ArticleIdList": ["15788131"]}, {"Citation": "Okamoto M., Ono M., Baba M. Potent inhibition of HIVtype 1 replication by an antiinflammatory alkaloid cepharanthinein chronically infected monocytic cells. AIDS Res. Hum. 1998;14:1239\u20131245. doi: 10.1089/aid.1998.14.1239.", "ArticleIdList": ["10.1089/aid.1998.14.1239", "9764907"]}, {"Citation": "Mulinacci N., Innocenti M., Gallori S., Romani A., LaMarca G., Vincieri F.F. Optimization of the chromatographic determination of polyphenols in the aerial parts of Cichoriumintybus L. Chromatographia. 2001;24:455\u2013461. doi: 10.1007/BF02491199.", "ArticleIdList": ["10.1007/BF02491199"]}, {"Citation": "Ziamajidi N., Khagjani S., Hassanzadeh G., Vardasbi S., Ahmadian S., Nowrouzi A. Amelioration by chicory seed extract of diabetes-and oleic acid-inducednon-alcoholicfattyliverdisease(NAFLD)/non-alcoholicsteato- hepatitis (NASH) via modulkation of PPAR\u03b1 and SREBP-1. Food Chem. Toxicol. 2013;58:198\u2013209. doi: 10.1016/j.fct.2013.04.018.", "ArticleIdList": ["10.1016/j.fct.2013.04.018", "23603006"]}, {"Citation": "Peng Y., Sun Q., Park Y. The Bioactive Effects of Chicoric Acid As a Functional Food Ingredient. J. Med. Food. 2019;22:645\u2013652. doi: 10.1089/jmf.2018.0211.", "ArticleIdList": ["10.1089/jmf.2018.0211", "30897018"]}, {"Citation": "Ara\u00fajo C.C., Leon L.L. Biological activities of Curcuma longa L. Mem Inst. Oswaldo Cruz. 2001;96:723\u2013728. doi: 10.1590/S0074-02762001000500026.", "ArticleIdList": ["10.1590/S0074-02762001000500026", "11500779"]}, {"Citation": "Soni V.K., Mehta A., Ratre Y.K., Tiwari A.K., Amit A., Singh R.P., Sonkar S.C., Chaturvedi N., Shukla D., Vishvakarma N.K. Curcumin, a traditional spice component, can hold the promise against COVID-19? Eur. J. Pharmacol. 2020;886:173551. doi: 10.1016/j.ejphar.2020.173551.", "ArticleIdList": ["10.1016/j.ejphar.2020.173551", "PMC7832734", "32931783"]}, {"Citation": "Siviero A., Gallo E., Maggini V., Gori L., Mugelli A., Firenzuoli F., Vannacci A. Curcumin, a golden spice with a low bioavailability. J. Herb. Med. 2015;5:57\u201370. doi: 10.1016/j.hermed.2015.03.001.", "ArticleIdList": ["10.1016/j.hermed.2015.03.001"]}, {"Citation": "Prakash D., Suri S., Upadhyay G., Singh B.N. Total phenol, antioxidant and free radical scavenging activities of some medicinal plants. Int. J. Food Sci. Nutr. 2007;58:18\u201328. doi: 10.1080/09637480601093269.", "ArticleIdList": ["10.1080/09637480601093269", "17415953"]}, {"Citation": "Sivaprabha J., Dharani B., Padma P.R., Sumathi S. Induction of DNA damage by the leaves and rhizomes of Curcuma amada Roxb in breast cancer cell lines. J. Acute Dis. 2015;4:12\u201317. doi: 10.1016/S2221-6189(14)60075-5.", "ArticleIdList": ["10.1016/S2221-6189(14)60075-5"]}, {"Citation": "Mahadevi R., Kavitha R. Phytochemical and pharmacological properties of Curcuma amada: A Review. Int. J. Res. Pharm. Sci. 2020;11:3546\u20133555. doi: 10.26452/ijrps.v11i3.2510.", "ArticleIdList": ["10.26452/ijrps.v11i3.2510"]}, {"Citation": "Gurung P., De P. Spectrum of biological properties of cinchona alkaloids: A brief review. J. Pharmacogn. Phytochem. 2017;6:162\u2013166."}, {"Citation": "O\u2019Neill E.J., Termini D., Albano A., Tsiani E. Anti-Cancer Properties of Theaflavins. Molecules. 2021;26:987. doi: 10.3390/molecules26040987.", "ArticleIdList": ["10.3390/molecules26040987", "PMC7917939", "33668434"]}, {"Citation": "Tong T., Liu Y., Kang J., Zhang C., Kang S. Antioxidant Activity and Main Chemical Components of a Novel Fermented Tea. Molecules. 2019;24:2917. doi: 10.3390/molecules24162917.", "ArticleIdList": ["10.3390/molecules24162917", "PMC6720624", "31408939"]}, {"Citation": "Behl T., Sharma A., Sharma L., Sehgal A., Zengin G., Brata R., Fratila O., Bungau S. Exploring the Multifaceted Therapeutic Potential of Withaferin A and Its Derivatives. Biomedicines. 2020;8:571. doi: 10.3390/biomedicines8120571.", "ArticleIdList": ["10.3390/biomedicines8120571", "PMC7762146", "33291236"]}, {"Citation": "Wang G., Xu L., Liu W., Xu W., Mu Y., Wang Z., Huang X., Li L. New anti-inflammatory withanolides from Physalis pubescens fruit. Fitoterapia. 2020;146:104692. doi: 10.1016/j.fitote.2020.104692.", "ArticleIdList": ["10.1016/j.fitote.2020.104692", "32717293"]}, {"Citation": "Tan J., Liu Y., Cheng Y., Sun Y., Pan J., Guan W., Li X., Huang J., Jiang P., Guo S., et al. New withanolides with anti-inflammatory activity from the leaves of Datura metel L. Bioorganic Chem. 2020;95:103541. doi: 10.1016/j.bioorg.2019.103541.", "ArticleIdList": ["10.1016/j.bioorg.2019.103541", "31927334"]}, {"Citation": "Jung Y., Lee J., Kim H.K., Moon B.C., Ji Y., Ryu D.H., Hwang G.S. Metabolite profiling of Curcuma species grown in different regions using 1HNMR spectroscopy and multivariate analysis. Analyst. 2012;137:5597\u20135606. doi: 10.1039/c2an35397k.", "ArticleIdList": ["10.1039/c2an35397k", "23066525"]}, {"Citation": "Kamazeri T.S.A.T., Samah O.A., Taher M., Susanti D., Qaralleh H. Antimicrobial activity and essential oils of Curcuma aeruginosa, Curcuma mangga, and Zingiber cassumunar from Malaysia. Asian Pac. J. Trop. Med. 2012;5:202\u2013209. doi: 10.1016/S1995-7645(12)60025-X.", "ArticleIdList": ["10.1016/S1995-7645(12)60025-X", "22305785"]}, {"Citation": "Khaerunnisa S., Kurniawan H., Awaluddin R., Suhartati S., Soetjipto S. Potential Inhibitor of COVID-19 Main Protease (Mpro) From Several Medicinal Plant Compounds by Molecular Docking Study. Preprints. 2020 doi: 10.20944/preprints202003.0226.v1.", "ArticleIdList": ["10.20944/preprints202003.0226.v1"]}, {"Citation": "Crosby D.C., Lei X.Y., Gibbs C.G., McDougall B.R., Robinson W.E., Reinecke M.G. Design, synthesis, and biological evaluation of novel hybrid dicaffeoyltartaric/diketo acid and tetrazole-substituted lchicoric acid analogue inhibitors of human immunodeficiency virus type 1 integrase. J. Med. Chem. 2010;53:8161\u20138175. doi: 10.1021/jm1010594.", "ArticleIdList": ["10.1021/jm1010594", "20977258"]}, {"Citation": "Hazuda D.J., Felock P., Witmer M., Wolfe A., Stillmock K., Grobler J.A., Espeseth A., Gabryelski L., Schleif W., Blau C. Inhibitors of strand transfer that prevent integration and inhibit HIV-1 replication in cells. Science. 2000;287:646\u2013650. doi: 10.1126/science.287.5453.646.", "ArticleIdList": ["10.1126/science.287.5453.646", "10649997"]}, {"Citation": "Reinke R.A., Lee D.J., McDougall B.R. l-Chicoric acid inhibits human immunodeficiency virus type 1 integration in vivo and is a noncompetitive but reversible inhibitor of HIV-1 integrase in vitro. Virology. 2004;326:203\u2013219. doi: 10.1016/j.virol.2004.06.005.", "ArticleIdList": ["10.1016/j.virol.2004.06.005", "15302207"]}, {"Citation": "Moshe R., Paul O., Igor K. Cepharanthine: A review of the antiviral potential of a Japanese-approved alopecia drug in COVID-19. Pharmacol. Rep. 2020;72:1509\u20131516.", "ArticleIdList": ["PMC7375448", "32700247"]}, {"Citation": "Ohashi H., Watashi K., Saso W., Shionoya K., Iwanami S., Hirokawa T., Shirai T., Kanaya S., Ito Y., Kim K.S., et al. Potential anti-COVID-19 agents, cepharanthine and nelfinavir, and their usage for combination treatment. iScience. 2021;23:102367. doi: 10.1016/j.isci.2021.102367.", "ArticleIdList": ["10.1016/j.isci.2021.102367", "PMC7997640", "33817567"]}, {"Citation": "Lan J., Ge J., Yu J., Shan S., Zhou H., Fan S., Zhang Q., Shi X., Wang Q., Zhang L. Structure of the SARS-CoV-2 spike receptor-binding domain bound to the ACE2 receptor. Nature. 2020;581:215\u2013220. doi: 10.1038/s41586-020-2180-5.", "ArticleIdList": ["10.1038/s41586-020-2180-5", "32225176"]}, {"Citation": "Walls A.C., Park Y.J., Tortorici M.A., Wall A., McGuire A.T., Veesler D. Structure, function, and antigenicity of the SARS-CoV-2 spike glycoprotein. Cell. 2020;181:281\u2013292. doi: 10.1016/j.cell.2020.02.058.", "ArticleIdList": ["10.1016/j.cell.2020.02.058", "PMC7102599", "32155444"]}, {"Citation": "Deguchi A. Curcumin targets in inflammation and cancer. Endocr. Metab. Immune Disord. Drug Targets. 2015;15:88\u201396. doi: 10.2174/1871530315666150316120458.", "ArticleIdList": ["10.2174/1871530315666150316120458", "25772169"]}, {"Citation": "Pulido-Moran M., Moreno-Fernandez J., Ramirez-Tortosa C., Ramirez-Tortosa M. Curcumin and Health. Molecules. 2016;21:264. doi: 10.3390/molecules21030264.", "ArticleIdList": ["10.3390/molecules21030264", "PMC6273481", "26927041"]}, {"Citation": "Kim Y., Clifton P. Curcumin, Cardiometabolic Health and Dementia. Int. J. Environ. Res. Public Health. 2018;15:2093. doi: 10.3390/ijerph15102093.", "ArticleIdList": ["10.3390/ijerph15102093", "PMC6210685", "30250013"]}, {"Citation": "Lelli D., Sahebkar A., Johnston T.P., Pedone C. Curcumin use in pulmonary diseases: State of the art and future perspectives. Pharmacol. Res. 2017;115:133\u2013148. doi: 10.1016/j.phrs.2016.11.017.", "ArticleIdList": ["10.1016/j.phrs.2016.11.017", "27888157"]}, {"Citation": "Bright J.J. Curcumin and autoimmune disease. Adv. Exp. Med. Biol. 2007;595:425\u2013451.", "ArticleIdList": ["17569223"]}, {"Citation": "Sordillo P.P., Helson L. Curcumin Suppression of Cytokine Release and Cytokine Storm. A Potential Therapy for Patients with Ebola and Other Severe Viral Infections. In Vivo. 2015;29:1\u20134.", "ArticleIdList": ["25600522"]}, {"Citation": "Achan J., Talisuna A.O., Erhart A., Yeka A., Tibenderana J.K., Baliraine F.N., Rosenthal P.J., D\u2019Alessandro U. Quinine, an old anti-malarial drug in a modern world: Role in the treatment of malaria. Malar. J. 2011;10:144. doi: 10.1186/1475-2875-10-144.", "ArticleIdList": ["10.1186/1475-2875-10-144", "PMC3121651", "21609473"]}, {"Citation": "Lipinski C.A., Lombardo F., Dominy B.W., Feeney P.J. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv. Drug Deliv. Rev. 1997;23:3\u201325. doi: 10.1016/S0169-409X(96)00423-1. reprinted in Adv. Drug Deliv. Rev. 2001, 46, 3\u201326.", "ArticleIdList": ["10.1016/S0169-409X(96)00423-1", "11259830"]}, {"Citation": "Lipinski C.A. Lead- and drug-like compounds: The rule-of-five revolution. Drug Discov. Today Technol. 2004;1:337\u2013341.", "ArticleIdList": ["24981612"]}, {"Citation": "Clark D.E. Rapid calculation of polar molecular surface area and its application to the prediction of transport phenomena 1. Prediction of intestinal absorption. J. Pharm. Sci. 1999;88:807\u2013814.", "ArticleIdList": ["10430547"]}, {"Citation": "Chang L.C.W., Spanjersberg R.F., von Frijtag Drabbe K., Unzel J.K., Mulder-Krieger T., van den Hout G., Beukers M.W., Brussee J., Ijzerman A.P. 2,4,6-Trisubstituted pyrimidines as a new class of selective adenosine A, receptor antagonists. J. Med. Chem. 2004;47:6529\u20136540. doi: 10.1021/jm049448r.", "ArticleIdList": ["10.1021/jm049448r", "15588088"]}, {"Citation": "Veber D.F., Johnson S.R., Cheng H.Y., Smith B.R., Ward K.W., Kopple K.D. Molecular properties that influence the oral bioavailability of drug candidates. J. Med. Chem. 2002;45:2615\u20132623. doi: 10.1021/jm020017n.", "ArticleIdList": ["10.1021/jm020017n", "12036371"]}, {"Citation": "Andersson S., Antonsson M., Elebring M., Jansson-Lofmark R., Weidolf L. Drug metabolism and pharmacokinetic strategies for oligonucleotide- and mRNA-based drug development. Drug Discov. Today. 2018;23:1733\u20131745. doi: 10.1016/j.drudis.2018.05.030.", "ArticleIdList": ["10.1016/j.drudis.2018.05.030", "29852223"]}, {"Citation": "Yu J., Zhou Z., Tay-Sontheime J., Levy R.H., Ragueneau-Majlessi I. Intestinal Drug Interactions Mediated by OATPs: A Systematic Review of Preclinical and Clinical Findings. J. Pharm. Sci. 2017;106:2312\u20132325. doi: 10.1016/j.xphs.2017.04.004.", "ArticleIdList": ["10.1016/j.xphs.2017.04.004", "28414144"]}, {"Citation": "Lynch T., Price A. The effect of cytochrome P450 metabolism on drug response, interactions, and adverse effects. Am. Fam. Physician. 2007;1:391\u2013396.", "ArticleIdList": ["17708140"]}, {"Citation": "Paz S., Vilasco M., Werden S.J., Arguello M., Joseph-Pillai D., Zhao T., Nguyen T.L., Sun Q., Meurs E.F., Lin R. A functional C-terminal TRAF3- binding site in MAVS participates in positive and negative regulation of the IFN antiviral response. Cell Res. 2011;21:895\u2013910. doi: 10.1038/cr.2011.2.", "ArticleIdList": ["10.1038/cr.2011.2", "PMC3203699", "21200404"]}, {"Citation": "Gao Y., Yan L., Huang Y., Liu F., Zhao Y., Cao L., Wang T., Sun Q., Ming Z., Zhang L., et al. Structure of the RNA-dependent RNA polymerase from COVID-19 virus. Science. 2020;368:779\u2013782. doi: 10.1126/science.abb7498.", "ArticleIdList": ["10.1126/science.abb7498", "PMC7164392", "32277040"]}, {"Citation": "Berman H.M., Battistuz T., Bhat T. The protein data bank. Acta Crystallogr. Sect. D Biol. Crystallogr. 2002;58:899\u2013907. doi: 10.1107/S0907444902003451.", "ArticleIdList": ["10.1107/S0907444902003451", "12037327"]}, {"Citation": "Gim\u00e9nez B.G., Santos M.S., Ferrarin M., Dos Santos Fernandes J.P. Evaluation of blockbuster drugs under the rule-of-five. Pharmazie. 2010;65:148\u2013152.", "ArticleIdList": ["20225662"]}, {"Citation": "Afonine P.V., Klaholz B.P., Moriarty N.W., Poon B.K., Sobolev O.V., Terwilliger T.C., Adams P.D., Urzhumtsev A. New tools for the analysis and validation of cryo-EM maps and atomic models. Acta Crystallogr. D Struct. Bio. 2018;74:814\u2013840. doi: 10.1107/S2059798318009324.", "ArticleIdList": ["10.1107/S2059798318009324", "PMC6130467", "30198894"]}, {"Citation": "Pettersen E.F., Goddard T.D., Huang C.C., Couc G.S., Greenblatt D.M., Meng E.C., Ferrin T.E. UCSF Chimera\u2014A visualization system for exploratory research and analysis. J. Comput. Chem. 2004;25:1605\u20131612. doi: 10.1002/jcc.20084.", "ArticleIdList": ["10.1002/jcc.20084", "15264254"]}], "ReferenceList": []}], "History": [{"Year": "2022", "Month": "1", "Day": "4"}, {"Year": "2022", "Month": "2", "Day": "25"}, {"Year": "2022", "Month": "2", "Day": "26"}, {"Year": "2022", "Month": "5", "Day": "14", "Hour": "1", "Minute": "22"}, {"Year": "2022", "Month": "5", "Day": "15", "Hour": "6", "Minute": "0"}, {"Year": "2022", "Month": "5", "Day": "18", "Hour": "6", "Minute": "0"}, {"Year": "2022", "Month": "4", "Day": "20"}], "PublicationStatus": "epublish", "ArticleIdList": ["35566014", "PMC9100219", "10.3390/molecules27092662", "molecules27092662"]}}], "PubmedBookArticle": []}